Article Open Access

Quality by Design in Bioprocess Development: Integrating Risk, Data, and Regulatory Strategy

Sai Surya Raja Amogha Tenneti

Abstract


Quality by Design (QbD) has become a fundamental paradigm in modern biopharmaceutical manufacturing by integrating quality assurance throughout the entire product lifecycle rather than relying solely on end-product testing. This systematic approach emphasizes scientific process understanding, risk-based decision making, and continuous process improvement to ensure consistent product quality and regulatory compliance. This paper examines the application of QbD principles in upstream and integrated bioprocess development, with particular emphasis on establishing robust manufacturing processes through structured risk assessment and data-driven optimization. The framework focuses on the identification and evaluation of Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs) using formal risk management methodologies to determine the factors that most significantly influence product quality. Experimental Design (Design of Experiments, DoE), multivariate statistical analysis, and advanced process analytical technologies are integrated to characterize process behavior, optimize operating conditions, and define reliable design spaces that support process robustness and scalability. In addition, real-time process monitoring and online measurement technologies enable proactive process control, early deviation detection, and continuous verification of manufacturing performance throughout production. The study further discusses how QbD facilitates lifecycle management by supporting adaptive process optimization, knowledge management, and continuous improvement while meeting evolving regulatory expectations established by international agencies. Particular attention is given to the implementation of Real-Time Release Testing (RTRT) and Continuous Process Verification (CPV) as essential components of modern quality systems that reduce testing delays and improve manufacturing efficiency. The findings demonstrate that QbD provides a comprehensive engineering and quality management framework for developing reproducible, scalable, and compliant biopharmaceutical manufacturing processes. By integrating scientific knowledge, statistical methodologies, risk assessment, and continuous monitoring, QbD enhances product consistency, operational reliability, regulatory compliance, and long-term manufacturing sustainability across the entire bioprocess lifecycle

Keywords


Analytics, Bioprocess Development, Lifecycle Management, Quality by Design, Regulatory Strategy

References


S. Mitragotri, P. A. Burke, and R. Langer, "Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies," Nat. Rev. Drug Discov., vol. 13, no. 9, pp. 655–672, 2014.

A. Richmond, "Cell response to environmental factors," in Handbook of microalgal mass culture (1986), CRC Press, 2017, pp. 69–100.

J. G. Duarte, M. G. Duarte, A. P. Piedade, and F. Mascarenhas-Melo, "Rethinking pharmaceutical industry with quality by design: application in research, development, manufacturing, and quality assurance," AAPS J., vol. 27, no. 4, p. 96, 2025.

A. Abend et al., "Dissolution testing in drug product development: workshop summary report," AAPS J., vol. 21, no. 2, p. 21, 2019.

D. K. Babi et al., "Opportunities and challenges for model utilization in the biopharmaceutical industry: current versus future state," Curr. Opin. Chem. Eng., vol. 36, p. 100813, 2022.

M. Romero-Obon et al., "Scale-Agnostic Models Based on Dimensionless Quality by Design as Pharmaceutical Development Accelerator," Pharmaceuticals, vol. 18, no. 7, p. 1033, 2025.

S. Yang et al., "Aspects and implementation of pharmaceutical quality by design from conceptual frameworks to industrial applications," Pharmaceutics, vol. 17, no. 5, p. 623, 2025.

C. Benetti and A. A. Benetti, "Quality by design in formulation development," in Introduction to Quality by Design (QbD) from Theory to Practice, Springer, 2024, pp. 139–159.

D. Nithyanantham, A. Nair, and U. Y. Nayak, "Leveraging artificial intelligence for advancements in liquid dosage formulations in the pharmaceutical industry," Ther. Innov. & Regul. Sci., vol. 59, no. 5, pp. 1004–1031, 2025.

M. B. S. Gonçalves, P. Hoffmann, M. Pereira-Silva, and F. Mascarenhas-Melo, "Quality by design in advanced anticancer therapeutics: bridging design space, manufacturing, and clinical performance," Expert Opin. Drug Deliv., pp. 1–22, 2026.

G. Towler and R. Sinnott, Chemical engineering design: principles, practice and economics of plant and process design. Butterworth-Heinemann, 2021.

G. K. Webster, G. D. Doddridge, and L. Kott, Process Analytical Technology in Pharma: Foundations for the Analytical Scientist. CRC Press, 2026.

B. Jagan, P. N. Murthy, A. K. Mahapatra, and R. K. Patra, "Quality by Design (QbD): Principles, underlying concepts, and regulatory prospects," Thai J. Pharm. Sci., vol. 45, no. 1, pp. 54–69, 2021.

C.-F. Mandenius, "Measurement Technologies for Upstream and Downstream Bioprocessing," 2021, MDPI.

J. Möller, Bioprocess Systems Engineering Applications in Pharmaceutical Manufacturing. MDPI-Multidisciplinary Digital Publishing Institute, 2022.

M. Lutfor, M. Al, F. Nadarkhani, M. Nezab, and others, "Advanced dissolution testing for novel drug formulations: challenges, emerging methods, and regulatory perspectives," J. Angiother., vol. 9, no. 1, pp. 1–16, 2025.

W. A. Dayyih and R. Awad, "Revolutionizing drug development: The role of quality by design (QbD) in modern pharmaceutical analysis," J. Pharm. Sci. Comput. Chem., vol. 1, no. 1, pp. 26–37, 2025.

S. Zobel-Roos et al., "Accelerating biologics manufacturing by modeling or: is approval under the QbD and PAT approaches demanded by authorities acceptable without a digital-twin?," Processes, vol. 7, no. 2, p. 94, 2019.

L. Castillo-Henr’iquez et al., "Quality by design: a suitable methodology in industrial pharmacy for Costa Rican universities," Sci. Pharm., vol. 90, no. 2, p. 34, 2022.

A. M. Kaleem, J. Koilpillai, D. Narayanasamy, and A. Kaleem, "Mastering quality: uniting risk assessment with quality by design (QbD) principles for pharmaceutical excellence," Cureus, vol. 16, no. 8, 2024.

A. Rajora and G. Chhabra, "Quality by design approach: regulatory need, current, and future perspective," Asian J Pharm Clin Res, vol. 14, no. 6, pp. 29–35, 2021.

L. Galvis et al., "Retrospective quality by design r (QbD) for lactose production using historical process data and design of experiments," Comput. Ind., vol. 141, p. 103696, 2022.

R. Foresti, S. Rossi, M. Magnani, C. G. Lo Bianco, and N. Delmonte, "Smart society and artificial intelligence: big data scheduling and the global standard method applied to smart maintenance," Engineering, vol. 6, no. 7, pp. 835–846, 2020.

K. M. Goni, A. Mohammed, S. Sundararajan, and S. I. Kassim, "Proactive Risk Management in Smart Manufacturing: A Comprehensive Approach to Risk Assessment and Mitigation," in Artificial Intelligence Solutions for Cyber-Physical Systems, Auerbach Publications, 2024, pp. 139–164.

C. Buvé et al., "Application of multivariate data analysis for food quality investigations: An example-based review," Food Res. Int., vol. 151, p. 110878, 2022.

R. Piippo, K. Niinimäki, and M. Aakko, "Fit for the future: Garment quality and product lifetimes in a CE context," Sustainability, vol. 14, no. 2, p. 726, 2022.

R. Kapadia, G. Shevalkar, U. Das, V. Singhai, D. Bari, and C. V Pardeshi, "Introduction to quality by design," in Introduction to quality by design (QbD) from theory to practice, Springer, 2024, pp. 1–33.

W. Alshaer et al., "Quality by design approach in liposomal formulations: Robust product development," Molecules, vol. 28, no. 1, p. 10, 2022.

B. Toussaint, A. Munoz-Pineiro, J. Pirnay, and others, "Overview and Outlook of Phage Therapy and Phage Biocontrol," Publ. Off. Eur. Union Luxemb., 2024.

A. Butean, I. Cutean, R. Barbero, J. Enriquez, and A. Matei, "A review of artificial intelligence applications for biorefineries and bioprocessing: from data-driven processes to optimization strategies and real-time control," Processes, vol. 13, no. 8, p. 2544, 2025.

H. Ali et al., "Machine Learning-Enabled NIR Spectroscopy. Part 3: hyperparameter by design (HyD) based ANN-MLP Optimization, model Generalizability, and model transferability," AAPS PharmSciTech, vol. 24, no. 8, p. 254, 2023.

G. Hole, A. S. Hole, and I. McFalone-Shaw, "Digitalization in the pharmaceutical industry: What to focus on under the digital implementation process?" Int. J. Pharm. X, vol. 3, p. 100095, 2021.

L. Chemmalil, C. Chumsae, G. Li, and A. Leone, "Perspective Chapter: Advanced Process Control and Automation With Special Focus on Emerging Continuous Bioprocessing," in Technologies in Cell Culture-A Journey From Basics to Advanced Applications, IntechOpen, 2023.

H. Narayanan et al., "Bioprocessing in the digital age: the role of process models," Biotechnol. J., vol. 15, no. 1, p. 1900172, 2020.

F. Palladino et al., "Bioreactors: applications and innovations for a sustainable and healthy future—a critical review," Appl. Sci., vol. 14, no. 20, p. 9346, 2024.




DOI: https://doi.org/10.52088/ijesty.v6i3.1873

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 Sai Surya Raja Amogha Tenneti

International Journal of Engineering, Science, and Information Technology (IJESTY) eISSN 2775-2674